Ibandronat Spirig HC 150 mg Monatstabletten
Ibandronat Spirig HC 150 mg Monatstabletten is a medicine authorised by Swissmedic under authorisation number 63119. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 March 2013 and the authorisation is valid without a time limit. ATC code M05BA06 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 63119 |
|---|---|
| Name | Ibandronat Spirig HC 150 mg Monatstabletten |
| Full name | Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA06 |
| First authorisation | 26 March 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten | B | 26 March 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Tablette(n) | M05BA06 | 07.99.0. | B |
| 4 | 3 | Tablette(n) | M05BA06 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ibandronat Spirig HC 150 mg Monatstabletten authorised in Switzerland?
Yes. Ibandronat Spirig HC 150 mg Monatstabletten is authorised by Swissmedic under authorisation number 63119, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ibandronat Spirig HC 150 mg Monatstabletten have?
Ibandronat Spirig HC 150 mg Monatstabletten is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ibandronat Spirig HC 150 mg Monatstabletten?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.